The ‘H' word: Listen to the doctor when choosing 600.xx codes

Why This Topic Matters

Using the wrong diagnosis category on prostate claims can affect medical necessity review and payer acceptance, especially when documentation wording and carrier policies do not align. The topic is important for urology coders, billers, and reimbursement specialists who need to match physician documentation with payer expectations.

Article Sections

1. Payer policy considerations for prostate procedures

   This section discusses how payer policies may differ for prostate biopsy and other prostate-related procedures. It also addresses how diagnosis selection can vary by carrier and clinical context.

2. Clinical and coding distinctions in prostate enlargement terminology

   This section explains the distinction between different medical terms used for prostate enlargement and how clinicians may describe the condition. It also notes how coding interpretation relates to documentation language and pathology versus clinical findings.

3. Guide to hyperplasia and hypertrophy diagnosis codes

   This section presents the main ICD-9-CM diagnosis group used when the documentation refers to benign prostate enlargement. It summarizes the categories included in the series and the structure of the related subcategories.